prove islet B-cell function whereas the effects of overinsulinisation are unclear. Pancreatic islet B-cell function was therefore studied after overinsulinisation of normal rats for 4 weeks (fed blood glucose 2.2-4.5 mmol/1, controls 4.1-7.0 mmol/1). Insulin secretion was assessed by a 3-h hyperglycaemic clamp (10.0 mmol/1) performed 1, 48, and 120 h after insulin withdrawal (n---6 in each group). When the clamp was performed 1 h after insulin withdrawal, clamp insulin concentration was 1.6+0.1 ~xg/1, compared to 9.3 +-1.0 lxg/1 in control rats. The integrated area under the plasma insulin concentration curve was also significantly decreased (4.8+0.4 vs 20.3+2.2 ixg.l-l.h -1, p<0.001), but recovered to 9.4+l.0gg-l-l-h-1 after 48h, and to 17.5 + 1.4 l-tg" 1-1. h-1 after 120 h. Pancreatic insulin contents were decreased at I h (6+_1 ~tg/g wet wt) and 48 h (54_+ 12 ~tg/g wet wt) but not at 120 h (221 +_ 30 ~tg/g wet wt) after withdrawal (controls, 303 _+ 29 gg/g wet wt) and there was a strong relationship with pancreatic preproinsulin mRNA and the clamp insulin response. Thus, overinsulinisation with prolonged periods of low blood glucose concentrations impairs islet B-cell function, but is reversible over 5 days.
17.5 + 1.4 l-tg" 1-1. h-1 after 120 h. Pancreatic insulin contents were decreased at I h (6+_1 ~tg/g wet wt) and 48 h (54_+ 12 ~tg/g wet wt) but not at 120 h (221 +_ 30 ~tg/g wet wt) after withdrawal (controls, 303 _+ 29 gg/g wet wt) and there was a strong relationship with pancreatic preproinsulin mRNA and the clamp insulin response. Thus, overinsulinisation with prolonged periods of low blood glucose concentrations impairs islet B-cell function, but is reversible over 5 days.
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Current management of the Type 1 (insulin-dependent) diabetic patient emphasises tight metabolic control in an effort to prevent the late tissue complications of diabetes, and in the early phase to preserve residual islet B-cell function. Intensive insulin injection therapy is, however, associated with hyperinsulinaemia [1] and very commonly with long periods of asymptomatically low blood glucose concentrations [2] . By analogy with the transient diabetic state observed in patients and rats after successful removal of a functioning insulinoma [3] [4] [5] , prolonged periods of hyperinsulinaemia and low blood glucose concentrations might be expected to impair rather than preserve islet B-cell function. As insulin secreting tumours may also produce other islet hormones [6] , it is possible, however, that these might contribute to the observed impairment of normal islet B-cell function.
In order to study the effects of long-term overinsulinisation on islet B-cell function we have used a rat model in which fed blood glucose levels were kept below normal by daily subcutaneous insulin injection therapy. Islet B-cell function was assessed by the hyperglycaemic clamp technique [7] immediately after insulin withdrawal and also at 2 and 5 days after withdrawal to document the time course of B-cell recovery. To examine the relationship between impaired insulin biosynthesis and secretion we have also measured pancreatic insulin content and preproinsulin mRNA abundance.
Materials and methods

Animals
Male Sprague Dawley rats (Charles River, Wilmington, Mass, USA) were used. Rats weighing 130-140 g were treated for 3 weeks with daily subcutaneous injections of highly purified protamine zinc insulin (PZI) (Hypurin, CPI Pharmaceuticals, Wrexham, Clwyd, UK). Doses (3 to 5 U/day) were adjusted to maintain blood glucose concentrations in fed rats between 2.5 and 4.5 mmol/1. These concentrations were chosen to be below those found in normal fed rats whilst being close to concentrations found in 24-h fasted rats. Rats were then treated for a further 7 days with soluble insulin (Hoechst 21PH, Hoechst, Frankfurt am Main, FRG) delivered from subcutaneously implanted Alzet mini-osmotic pumps (154 mU/h; Alzet 2002, Palo Alto, Calif, USA). Blood glucose determinations were made three times a week on tail vein samples collected under ether anaesthesia. Indwelling cannulae for metabolic studies were implanted under ether anaesthesia in the external jugular and femoral veins 24 h before the experiment.
Hyperglycaemic clamp studies
Insulin secretion was assessed by the hyperglycaemic clamp technique in 8 normal control rats and in insulin overtreated rats, 1, 48, and 120 h after insulin withdrawal (A, B and C respectively; n =6 in each group). Rats were fasted for 6 h prior to study. In group A, after removal of Alzet pumps and food at 07.00 hours neutral soluble insulin (Humulin R, Eli Lilly, Indianapolis, Ind, USA) diluted in polygeline solution (Haemaccel, Hoechst) was infused intravenously for 5 h. This was necessary to maintain normoglycaemia prior to the clamp in this group of rats. The infusion rate (approximately 36 mU/h) was adjusted to maintain blood glucose between 3.5 and 4.5 mmol/1. The insulin infusion was discontinued 1 h prior to the clamp to allow for clearance of insulin from the plasma compartment. Normal control rats, and insulin overtreated rats in groups B and C received an infusion of Haemaccel alone at the same rate (0.04 ml/h).. Hyperglycaemic clamp studies commenced at 13.00 hours. After a basal blood sample (200 ]zl) for glucose and insulin determination, blood glucose was raised to 10.0 retool/1 and clamped at that level for 3 h by a variable infusion of a solution of 500 g/l glucose in water. This was delivered via the jugular venous cannula from a Harvard syringe pump (Harvard apparatus, South Natick, Mass, USA). Blood samples for glucose (30 ]xl) were taken at 5-10 min intervals from the femoral venous cannula and replaced with 0.15 mol/1 saline. Blood glucose concentration was monitored by the glucose oxidase method within 2 min of obtaining the sample. Blood samples for insulin (200 gl) were obtained at 10, 20, 30, 45, 60 min and then at 30-min intervals tmtil 180 min. The erythrocytes from these samples were washed with 0.15 mol/1 saline and returned to the animal via the femoral cannula.
At the end of the study the animals were anaesthetised by intravenous (i.v.) injection of amylobarbitone (0.02g in 200~tl 0.15 mol/1 saline). The pancreas was excised, ground in liquid nitrogen and the powder stored at -70~ for determination of pancreatic insulin content and preproinsulin mRNA abundance.
Diurnal blood glucose profiles after insulin withdrawal
ethidium bromide. The 28s and 18s RNA were visualised under UV light and photographed. Samples were not used unless the ratio of 28s RNA: 18s RNA was 1.5:1 or greater. To determine the integrity of the preproinsulin RNA, RNA from the gels was transferred to nylon filters (Zetabind, AMF Cuno, Meridan, Conn, USA) and hybridised to cDNA probe as described below. For dot blots, 5 lxg of total RNA was added to 20 ~tl of 10X SSC (1X SSC=0.15 mol/1 NaC1 0.015 tool/1 sodium citrate, pH 7.0), containing 50% v/v formaldehyde, and heated at 65~ for 10 rain. After adding 60 Ixl 15X SSC, the solution was applied to a nylon filter using a Minifold apparatus (Schleicher and Schuell, Inc., Keene, NH, USA). Pancreatic RNA from all rats was applied to a single filter. The filter was dried and baked for 2 h at 60~ For assessment of preproinsulin mRNA abundance the filter was prehybridised at 65 ~ C for at least 4 h, and then hybridised at 42 ~ C for 18 tl with 5 x 106 cpm of single stranded cDNA probe prepared as described below. After washing extensively, the filter was exposed to X-ray film with a Cronex intensifying screen (DuPont, Newton, Conn, USA) for 24 h at -70 ~ C. The autoradiogram was scanned with a scanning densitometer and the area under each curve determined.
To prepare the single stranded probe, a 193 base pair fragment from the plasmid pr12-SV40-46 was subcloned into M13 mp 19 [11] . This fragment extends from BamH1 site 8 bases from the initiator codon to an EcoR1 site in the second intron and corresponds to the coding sequence for the B chain and part of the C peptide [12] . Uniformly labelled, single-stranded DNA extending from the BamH1 site to a Hind III site in the vector and complementary to the coding strand was synthesized using the M13 template [13] .
Other assays
Insulin was measured by ethanol precipitation radioimmunoassay [14] (intra-assay coefficient of variation 6%) using a rat or human standard (Eli Lilly) as appropriate. Pancreatic insulin was determined on acid ethanol extracts of tissue using a rat insulin standard.
Statistical analysis
Results are expressed as means + SEM. The areas under the plasma insulin concentration curves were calculated using the trapezoidal rule. Significance of differences was assessed using Student's unpaired t-test. A p value of less than 0.05 was considered statistically significant.
Femoral venous cannulae were implanted 24 h prior to removal of Alzet pumps from 6 insulin overtreated rats. Six normal control rats were also studied. Animals were allowed free access to laboratory chow and water. Blood samples (30 ~tl) were taken at 6 h intervals for 48 h after insulin withdrawal for measurement of blood glucose concentration.
Results
Plasma insulin and blood glucose concentrations in ad libitum fed rats Pancreatic preproinsulin mRNA determination
Pancreatic RNA was extracted from aliquots of the frozen tissue as previously described 18, 9] . Briefly, tissue was weighed on a balance precooled to liquid nitrogen temperature and approximately 0.5 g was homogenised in 5 tool/1 guanidinethiocyanate/5% v/v [3-mercaptoethanol/50 mmol/1 Tris HC1, pH 7.5. RNA was isolated from the homogenate by centrifugation (25000rpm, 36h in an SW28s rotor) through a 5.7 mol/1 ceasinm chloride cushion. The total amount of RNA recovered was measured by resuspending the RNA pellet obtained after centrifugation through CsC1 and determining the OD260 in a Beckman spectrophotometer. To ascertain the integrity of the RNA preparations, 1-3 p.g of total RNA was fractionated on 1% agarose/2.2 mol/1 formaldehyde gels [10] and stained with Plasma insulin concentrations in the overinsulinised animals during the last week of insulin therapy from subcutaneously implanted Alzet pumps were increased (7.31 + 0.29 lag/l, human insulin standard) compared with normal controls (3A4+__0.25~tg/1, rat insulin standard). Mean blood glucose concentration in ad libitum fed overinsulinised rats (n=24) was 3.3+0.1mmol/1 compared with 5.6_+0.2retool/1 in normal controls (n---14). This compares with a blood glucose concentration of 3.6__+ 0.2 mmol/1 in 12 normal rats after a 24 h fast. This chronic hypoglycaemia and hyperinsulinaemia was associated with increased food consumption and at the time of venous cannula- Ad libitum fed blood glucose concentrations in 6insulin overtreated rats after insulin withdrawal ( 9 and 6 normal control rats (O----O); mean + SEM tion overinsulinised rats in group A were significantly heavier than the normal control rats (336+ 8 versus 298 + 4 g, p< 0.001). Body weight remained significantly increased following insulin withdrawal (group B, 327 + 6 g; group C 321 _+ 5 g; both p< 0.01 vs controls). After removal of Alzet pumps from a group of 6 rats, marked hyperglycaemia was observed within 6h (Fig.l) . Blood glucose concentration remained elevated for 24 h (Fig. 1) after which there was a steady decline until 48 h when concentrations in these ad libiturn fed rats were not statistically significantly different from control rats (t=2.111, 0.05 <p> 0.1).
Hyperglycaemic clamps
After stopping the i.v. insulin infusion in group A (1 h before study), there was a progressive increase in blood glucose concentration from normoglycaemia (4.2___ 0.1 mmol/1) to 6.3 _ 0.2 mmol/1. Blood glucose concentration was then higher than in normal control rats (4.5___ 0.1 mmol/l, p< 0.001). Basal glucose concentrations before the clamp in overinsulinised rats 48 h (group B) and 120 h (group C) after insulin withdrawal were also increased compared with controls (5.9 + 0.3 retool/1 and 5.1 +_ 0.1 mmol/1, respectively, both p<0.05). Despite this difference in blood glucose, basal insulin concentrations in group A (1.32 +_ 0.23 ~tg/1) were not different from those of control rats (1.37 + 0.14 lxg/1). Basal insulin concentrations in group B (2.17 _+ 0.28 Ixg/l) and group C (1.90+0.15~tg/1) were significantly increased compared with controls (both p< 0.05).
During the clamp target blood glucose of 10.0 retool/1 was attained by 15 min in all groups of rats (Fig.2) . In groups A and B, glucose requirement to maintain the clamp (Fig. 2 ) rapidly decreased to very low values after the initial prime, and was discontinued in ali the group A rats and in 3 of the group B rats by + 60 rain, Despite stopping the glucose infusion, blood glucose concentration in group A rats continued to rise and was 14.6 + 0.6 mmol/1 at + 180 min (Fig. 2, p< 0 .001 compared with controls). A small increase in blood glucose concentration was also observed in 3 rats in group B despite stopping the glucose infusion, accounting for the slightly higher glucose concentration at +180 min in this group (10.6_+ 0.2 mmol/l) compared with controls (10.0 + 0.1 mmol/1, p< 0.05). The mean blood glucose during the last 90min of the clamp was 10.0+ 0.1 mmol/1 (+SD) in group C and 10.0+ 0.1 mmol/1 (_+ SD) in the control group. In these two groups, the coefficient of variation of blood glucose level calculated for each animal was 4.1 +0.9% (+SD) and 5.2+1.3% respectively. In group C, the glucose infusion rate from + 120 to + 180 min remained significantly lower than in controls (183_+12 vs 240_+20gmol.min-l.kg -t, p < 0.05).
Insulin secretion in normal control rats increased throughout the 3 h hyperglycaemic clamp and steady state plasma insulin levels were not attained during the study (Fig. 2) . Insulin secretion was markedly impaired in groups A and B (Fig.2) , the areas under the plasma insulin concentration curves being significantly lower than in controls (Table 1 , both groups p<0.001). By 120 h after insulin withdrawal (group C) clamp insulin response was not different from control rats ( Table 1) .
Pancreatic insulin and preproinsulin mRNA content
Pancreatic insulin concentration was decreased in groups A and B compared with control rats (Table 1, p<0.001 for both) but not in groupC (221+30 vs 303+29p.g/g wet wt, t=1.992, NS). Recovery of total pancreatic RNA was increased in group A rats compared with normal controls (11.5 + 0.7 vs 8.4 _+ 0.7 mg/g wet wt, p<0.05) but was similar in groups B and C (10.1+1.6 and 7.5+0.9mg/g wet wt respectively). In all cases the ratio of 28 s RNA to 18 s RNA was 1.5 to 1 or greater and the preproinsulin mRNA could be visualised, after hybridisation to a radiolabelled probe, as a broad but discrete band of about 550 bases. Relative concentrations of preproinsuun mRNA in aliquots of total pancreatic RNA are shown in Figure 3 . The areas under the densitometric scanning curves were markedly decreased in group A rats compared with controls rats (24+7 vs 586+73 U/5 ~tg RNA, p<0.001). By 48 h after insulin withdrawal, preproinsulin mRNA content had increased to 35% of control (203 +77 U/5 ~tg RNA, p<0.005) and by 120 h was not different from that of control rats O94+41 U/5 ~tg RNA; Fig.3 ). Within group B there was wide variation in the preproinsulin mRNA abundance (46-440 U/5 ~tg RNA) and pancreatic insulin contents (21-97 ~tg/g wet wt) and a strong correlation was observed between these two variables (r=0.95) and between pancreatic insulin content and insulin response to the hypyerglycaemic clamp (r=0.83, p<0.05).
TableL Areas under the plasma insulin concentration curves (AUC) during the hyperglycaemic clamp and pancreatic insulin contents in overinsulinised rats 1 h (group A), 48 h (group B) and 120 h (group C) after insulin withdrawal and in normal control rats 
Discussion
In the present study we have examined the effects of chronic overinsulinisation on islet B-cell function in normal rats. Our findings of a transient diabetic state following insulin withdrawal are similar to those of Chick et al. [5] in rats with fimctioning insulinomas. That this impairment of B-cell function in rats with insulinomas is secondary to the hypoglycaemia rather than a direct feedback effect of insulin is suggested by the demonstration that prolonged intravenous glucose infusions led to B-cell recovery despite continuing tumour-associated hyperinsulinaemia [15] . Our findings may be contrasted with those of Chu and Goodner [16] who were unable to demonstrate abnormalities of insulin secretion following intravenous glucose and tolbutamide in normal rats treated by insulin injections for 5 months. These authors did, however, find a 50% decrease in pancreatic insulin content in the insulin treated rats [16] . A more sustained hypoglycaemia in the current study might possiMy account for the more profound effect demonstrated. The degree of hypoglycaemia achieved in the current study was, however, relatively mild, ad libitum fed blood glucose concen-trations being maintained close to levels found in normal fasted rats. Our observations are thus consistent with the decreased islet cell proliferation and islet volume found in food restricted rats and mice [17, 18] , and suggest that blood glucose elevations in the fed state, albeit small, play an important trophic role for normal islet function. Recovery of total RNA expressed per unit weight of frozen pancreatic tissue was increased 36% in group A rats compared with normal control rats. It is possible that this reflects the effect of hyperphagia and hyperinsulinaemia and hence increased glucose metabolism in the exocrine pancreas [19, 20] . Pancreatic preproinsulin mRNA was, however, profoundly decreased whether expressed in terms of pancreatic weight (5.2% of normal control value) or as a proportion of total pancreatic RNA (4.1% of control value).
Previous studies in rats chronically overinsulinised by insulin injection therapy have demonstrated both a decrease in number and size of islet B cells and a decrease in B-cell granules [21, 22] . Similar features are seen in the pancreas of insulinoma-bearing rats [5, 23] . These changes are thus likely to account for the delay in recovery of B-cell function following insulin withdrawal or tumour resection. Indeed, studies in insulinoma-bearing rats infused intravenously for 3 days with 50% glucose resulted in both B-cell hypertrophy and increased B-cell replication [13] in addition to an increase in preproinsulin mRNA abundance. As in the current study, the increase in preproinsulin mRNA content was delayed until 2-3 days after reversal of hypoglycaemia [15] . In the 3 groups of overinsulinised rats we have been able to demonstrate a clear relationship between pancreatic preproinsulin mRNA abundance, pancreatic insulin content and clamp insulin response. These findings are in keeping with a regulatory role of glucose on preproinsulin gene transcription and possibly mRNA translation. Whether chronic overinsulinisation is associated with a defect of insulin release per se, as has been found in islets cultured at low glucose concentrations for 6 days [24, 25] , cannot be answered from the current study. Such an abnormality if present would be very difficult to detect during the first 48 h after insulin withdrawal when both preproinsulin mRNA content and insulin content were profoundly decreased.
We have previously demonstrated that long-term overinsulinisation with mild hypoglycaemia is associated with a decrease in insulin sensitivity [26] . The elevated basal insulin and glucose concentrations in rats in groups B and C compared with control animals (Fig. 2) suggest that restoration of normal sensitivity is also delayed several days following insulin withdrawal. Interpretation however, is complicated by the increased body weights of the insulin overtreated animals.
Our findings may be important not only in relation to the insulin treated Type 1 diabetic patient with residual B-cell function but also in relation to other groups with impaired B-cell function treated by exogenous insulin therapy. These include insulintreated Type 2 (non-insulin-dependent) diabetic patients, recipients of pancreatic transplants and patients who have undergone partial pancreatectomy. Although modest improvement in metabolic control in Type 2 diabetic patients [27, 28] has been associated with improved B-cell function it may be prudent to avoid overinsulinisation in these groups.
Further studies are needed to examine whether intermittent overinsulinisation, as is most frequently encountered in patients on intensified insulin regimens, leads to impaired B-cell function, or whether continuous overinsulinisation is necessary. The observation that in normal subjects infused with insulin for 1 h, Cpeptide and insulin secretion remained suppressed for a period after return of blood glucose concentrations to basal levels [29] suggests that intermittent overinsulinisation may exert a significantly detrimental effect.
